Notice of Change: Extension of PAR-20-285 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)"
Notice Number:
NOT-NS-23-094

Key Dates

Release Date:

July 21, 2023

Related Announcements

  • July 29, 2020 - NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional). See NOFO PAR-20-285.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of an extension to PAR-20-285 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)" by one additional council round. Due to the extension, the following application due dates have been added/changed:

New Application Due Date: October 18, 2023

Resubmission/Revision Due Date(s): November 17, 2023

Expiration Date: November 18, 2023

Changes to the Key Dates are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Date(s)

New Applications: October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021; February 22, 2022; June 20, 2022; October 18, 2022; February 14, 2023, June 14, 2023 by 5:00 PM local time of applicant organization.

 Resubmission or Revision Applications:  November 18, 2020; March 22, 2021; July 14, 2021; November 18, 2021, March 22, 2022; July 20, 2022; November 18, 2022; March 14, 2023, July 23, 2023 by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit ReviewFebruary 2021, July 2021, October 2021, February 2022, July 2022, October 2022, February 2023, July 2023, October 2023
Advisory Council ReviewMay 2021, October 2021, January 2022, May 2022, October 2022, January 2023, May 2023, October 2023, January 2024
Earliest Start DateJune 2021, November 2021, February 2022, June 2022, November 2022, February 2023, June 2023, November 2023, February 2024
Expiration DateJuly 24, 2023

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Date(s)

New Applications: October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021; February 22, 2022; June 20, 2022; October 18, 2022; February 14, 2023, June 14, 2023, October 18, 2023 by 5:00 PM local time of applicant organization.

 Resubmission or Revision Applications:  November 18, 2020; March 22, 2021; July 14, 2021; November 18, 2021, March 22, 2022; July 20, 2022; November 18, 2022; March 14, 2023, July 23, 2023, November 17, 2023 by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit ReviewFebruary 2021, July 2021, October 2021, February 2022, July 2022, October 2022, February 2023, July 2023, October 2023, February 2024
Advisory Council ReviewMay 2021, October 2021, January 2022, May 2022, October 2022, January 2023, May 2023, October 2023, January 2024, May 2024
Earliest Start DateJune 2021, November 2021, February 2022, June 2022, November 2022, February 2023, June 2023, November 2023, February 2024, June 2024
Expiration DateNovember 18, 2023

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Scott Janis, Ph.D.
National Institute of Neurological Disorders & Stroke (NINDS)
Telephone: 301-496-9135
Email: JanisS@ninds.nih.gov